Brammer Bio Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:N/A
Industry:Pharma
Founded:2016
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Brammer Bio's estimated annual revenue is currently $124M per year.
  • Brammer Bio's estimated revenue per employee is $201,000

Employee Data

  • Brammer Bio has 617 Employees.
  • Brammer Bio grew their employee count by 53% last year.
  • Brammer Bio currently has 95 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
N/A445N/AN/A-N/A
#2
N/A411N/AN/A-N/A
#3
$43.8M218N/AN/A-N/A
#4
$1737.8M8646N/AN/A-N/A
#5
$26.1M130N/AN/A-N/A
#6
$30.3M38550%N/A-N/A
#7
$5.4M27N/AN/A-N/A
#8
$780.7M3884N/AN/A-N/A
#9
$20.5M102N/AN/A-N/A
#10
$17.3M8648%N/A-N/A
Missing a competitor? Contribute!?
Submit

Brammer Bio is a best-in-class viral vector contract development and manufacturing organization (CDMO) for companies developing gene-modified cell therapies and in vivo gene therapies. Brammer offers end-to-end CDMO services from Phase I/II in Florida through commercial manufacturing in Massachusetts. Brammer Bio provides clinical and commercial supply of viral vectors for in vivo gene and ex vivo modified-cell based therapies, process and analytical development, and regulatory support, enabling large pharma and biotech clients to accelerate the delivery of novel medicines to improve patient health. The Brammer team consists of extraordinary employees focused exclusively on serving the gene therapy needs of clients and their patients. We are Helping to Cure.® The management team is led by President and CEO Mark Bamforth; Chief Scientific Officer Dr. Richard Snyder, the founder of Florida Biologix, which was spun out of the University of Florida in 2015; and Chief Operating Officer Christopher Murphy. Brammer Bio offers a competitive benefits package, including medical, dental, vision, paid time off, holidays, 401(k) with a company match, incentive bonus, flexible spending account (FSA), and educational assistance.

keywords:Biotechnology,Healthcare,Pharmaceuticals

617

Number of Employees

$124M

Revenue (est)

95

Current Jobs

53%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Brammer Bio News

08/12/2019 - Brammer Bio in talks to build manufacturing site in ...

Brammer Bio is looking to build a pharma manufacturing facility in Norton, US. The viral vector manufacturers are attempting to finance this ...

09/06/2019 - Manufacturing market for viral vectors and plasmids set to boom

Just this year, Catalent bought out California-based Paragon Bioservices? and Thermo Fisher Scientific acquired Brammer Bio?, located in ...

09/06/2019 - “Global Viral Vector Development Service Market 2019 ...

“Global Viral Vector Development Service Market 2019 – Kaneka Eurogentec , FinVector , Brammer Bio , Cell and Gene rapy Catapult “.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
N/A628N/AN/A-N/A
#2
$191.5M628N/AN/A-N/A
#3
$134.4M640N/AN/A-N/A
#4
$99.8M644-12%$193M-N/A
#5
$211.9M656N/AN/A-N/A

Brammer Bio Executive Hires

DateNameTitleReference
2017-06-21Christopher MurphyChief Manufacturing OfficerArticle
2018-03-21Doug ChambersVP quality & regulatoryArticle
2019-01-04Steve FalconeChief Quality OfficerArticle

Brammer Bio New Location/Offices

DateLocationReference
2016-06-09San Francisco, CAArticle